Schultze Detlev, Weder Bruno, Cassinotti Pascal, Vitek Lucie, Krausse Konrad, Fierz Walter
Institute for Clinical Microbiology and Immunology, St. Gallen, Switzerland.
Swiss Med Wkly. 2004 Nov 27;134(47-48):700-4. doi: 10.4414/smw.2004.10766.
The optimal strategy for the diagnosis of herpes simplex virus (HSV) and varizella-zoster virus (VZV) disease of the central nervous system is the detection of viral DNA by polymerase chain reaction assay (PCR) in cerebrospinal fluid (CSF) and the examination of intrathecal production of specific antibodies. However, in acute neurological disease caused by either HSV or VZV, dual intrathecal synthesis of HSV-1, 2- as well as VZV-specific antibodies may be detectable and thus can hamper accurate aetiological diagnosis. This paper illustrates such equivocal findings in two case reports, investigates their frequency and discusses the possible reasons.
Consecutive CSF/serum pairs of two patients with central nervous system (CNS) disease were tested by HSV-1-, HSV-2-, and VZV-specific PCR and by different serological assays for detection of neurotropic viruses and bacteria. Additionally, the results of microbiological investigations of 1'155 CSF/serum samples were retrospectively analyzed for coincident intrathecal antibody synthesis against HSV-1, 2 and VZV.
Although only HSV-1 and VZV-specific DNA was detectable in the CSF of two patients with encephalitis and chronic meningitis, respectively, increasing intrathecal antibody production against both virus species could be demonstrated. Retrospective analysis of 1155 CSF/serum pairs revealed 55 (4.8%) pairs with evidence for intrathecally produced antibodies against either HSV-1, 2 (30/55) or VZV (14/55). Eleven of these 55 (20%) pairs showed intrathecal antibody-production against both virus species.
Patients with CNS infection with HSV and VZV can be diagnosed by detecting intrathecally produced virus-specific antibodies, in addition to virus-specific PCR. However, in an appreciable proportion of patients a correct diagnosis is hampered by coincidentally detected antibodies in CSF against both virus species. Possible reasons for these equivocal findings are given.
诊断中枢神经系统单纯疱疹病毒(HSV)和水痘-带状疱疹病毒(VZV)疾病的最佳策略是通过聚合酶链反应检测脑脊液(CSF)中的病毒DNA以及检测鞘内特异性抗体的产生。然而,在由HSV或VZV引起的急性神经系统疾病中,可能会检测到HSV-1、2以及VZV特异性抗体的双重鞘内合成,从而妨碍准确的病因诊断。本文通过两个病例报告阐述了这种模棱两可的发现,调查了其发生率并讨论了可能的原因。
对两名患有中枢神经系统(CNS)疾病的患者的连续脑脊液/血清样本进行HSV-1、HSV-2和VZV特异性PCR检测,以及通过不同的血清学检测方法检测嗜神经病毒和细菌。此外,回顾性分析了1155份脑脊液/血清样本的微生物学检测结果,以确定是否存在针对HSV-1、2和VZV的鞘内抗体合成。
虽然分别在两名患有脑炎和慢性脑膜炎的患者的脑脊液中仅检测到HSV-1和VZV特异性DNA,但可以证明针对这两种病毒的鞘内抗体产生增加。对1155对脑脊液/血清样本的回顾性分析显示,有55对(4.8%)样本有证据表明存在针对HSV-1、2(30/55)或VZV(14/55)的鞘内产生的抗体。这55对样本中有11对(20%)显示针对两种病毒的鞘内抗体产生。
除了病毒特异性PCR外,通过检测鞘内产生的病毒特异性抗体可以诊断患有HSV和VZV中枢神经系统感染的患者。然而,在相当一部分患者中,脑脊液中同时检测到针对两种病毒的抗体妨碍了正确诊断。文中给出了这些模棱两可发现的可能原因。